{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:56:10Z","timestamp":1789188970461,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T00:00:00Z","timestamp":1289260800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0013856","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T20:29:12Z","timestamp":1289334552000},"page":"e13856","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia"],"prefix":"10.1371","volume":"5","author":[{"given":"Romain","family":"Micol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayden","family":"Tajahmady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Balkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Quillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Dousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak","family":"Chanroeun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Madec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fontanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,11,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0272989X9701700402","article-title":"The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.","volume":"17","author":"JA Scharfstein","year":"1997","journal-title":"Med Decis Making"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1086\/344902","article-title":"Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis.","volume":"36","author":"Y Yazdanpanah","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.279.2.130","article-title":"The cost-effectiveness of preventing AIDS-related opportunistic infections.","volume":"279","author":"KA Freedberg","year":"1998","journal-title":"Jama"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/319348","article-title":"Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994\u20131998: regional variation and temporal trends.","volume":"32","author":"S Chariyalertsak","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/088922203762688586","article-title":"Human immunodeficiency virus type 1 subtype and other factors associated with extrapulmonary Cryptococcosis among patients in Thailand with AIDS.","volume":"19","author":"PN Amornkul","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/QAD.0b013e32832be0fc","article-title":"High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.","volume":"23","author":"JN Jarvis","year":"2009","journal-title":"Aids"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS.","volume":"23","author":"BJ Park","year":"2009","journal-title":"Aids"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1468-1293.2004.00199.x","article-title":"Primary prophylaxis for cryptococcal meningitis.","volume":"5","author":"L John","year":"2004","journal-title":"HIV Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1258\/095646204322637263","article-title":"Aetiology of meningitis in HIV-infected patients in a referral hospital in Phnom Penh, Cambodia.","volume":"15","author":"S Chhin","year":"2004","journal-title":"Int J STD AIDS"},{"key":"ref10","first-page":"17","article-title":"[Clinical aspects of AIDS at the Calmette hospital in Phnom Penh, Kingdom of Cambodia A report on 356 patients hospitalized in the Medicine \u201cB\u201d Department of the Calmette Hospital].","volume":"11","author":"K Pichith","year":"2001","journal-title":"Sante"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAI.0b013e31811ed32c","article-title":"Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.","volume":"45","author":"R Micol","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.","volume":"48","author":"JN Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings.","volume":"51","author":"DB Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jinf.2010.03.015","article-title":"The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts.","volume":"60","author":"P Pongsai","year":"2010","journal-title":"J Infect"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.","volume":"12","author":"CA Liechty","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref16","year":"2009"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.","volume":"50","author":"JR Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.aids.0000252060.80704.68","article-title":"Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.","volume":"20","author":"O Lortholary","year":"2006","journal-title":"Aids"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJMsa060247","article-title":"Cost-effectiveness of HIV treatment in resource-poor settings\u2013the case of Cote d'Ivoire.","volume":"355","author":"SJ Goldie","year":"2006","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.","volume":"126","author":"JW Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1128\/JCM.29.8.1616-1619.1991","article-title":"Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens.","volume":"29","author":"W Gade","year":"1991","journal-title":"J Clin Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAD.0b013e328012c54f","article-title":"Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.","volume":"21","author":"Y Madec","year":"2007","journal-title":"Aids"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/154510970400300302","article-title":"Successful public\/private donation programs: a review of the Diflucan Partnership Program in South Africa.","volume":"3","author":"AI Wertheimer","year":"2004","journal-title":"J Int Assoc Physicians AIDS Care (Chic Ill)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/338154","article-title":"A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.","volume":"34","author":"S Chariyalertsak","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/QAD.0b013e3280106d6a","article-title":"Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence.","volume":"20","author":"KM McCarthy","year":"2006","journal-title":"Aids"},{"key":"ref26","article-title":"Macroeconomics and health: investing in health for economic development."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/01.aids.0000180101.80888.c6","article-title":"Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV\/AIDS in Cote d'Ivoire: a trial-based analysis.","volume":"19","author":"Y Yazdanpanah","year":"2005","journal-title":"Aids"},{"key":"ref28","first-page":"747","article-title":"Cost-utility of tuberculosis prevention among HIV-infected adults in Kampala, Uganda.","volume":"11","author":"RK Shrestha","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/01.aids.0000174450.70874.30","article-title":"Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France.","volume":"19","author":"O Lortholary","year":"2005","journal-title":"Aids"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/605497","article-title":"Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.","volume":"49","author":"S Sungkanuparph","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-151-3-200908040-00138","article-title":"When to start antiretroviral therapy in resource-limited settings.","volume":"151","author":"RP Walensky","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/QAI.0b013e31815bad0c","article-title":"The impact of primary prophylaxis for cryptococcosis on fluconazole resistance in Candida species.","volume":"47","author":"A Apisarnthanarak","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.","volume":"43","author":"T Bicanic","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0013856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T09:08:09Z","timestamp":1636794489000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0013856"}},"subtitle":[],"editor":[{"given":"Landon","family":"Myer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,11,9]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0013856","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,9]]}}}